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Amyotrophic lateral sclerosis (ALS) is a fatal and progressive neurodegenerative disease.
Despite much research having been conducted about psychological issues involved in liv-
ing with ALS, anger, and resentment have yet to be investigated. Moreover, the construct
of “hope” has received little attention, so far. An online survey was created to investigate
hate, resentment, and hope issues in people with ALS, in relation to the willingness to
adopt a strict nutrient-dense diet if it were shown to increase longevity. Results indicate
that there is a high level of hope in the sample. People who have lived with ALS for more
time expressed a higher level of hope to live 10 years or more. Those who are married
were more likely to have hope of living 10 years or longer and more likely to have lower
levels of hate against ALS. Dietary self-care choices appear to be related to hope issues.
Resentment and hate tended to be higher in people who have had ALS for less time, and
in women. Despite some methodological limitations, the results suggest that hope, hate,
and resentment could be important issues to explore in future studies.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal and progressive neu-
rodegenerative disease, which affects motor neurons in the ante-
rior horn of the spinal cord, the brainstem, and the motor cortex.
It is a rare disease, with an incidence of 1.89 per 100,000/year
in western countries (Worms, 2001). People with ALS experience
a progressive muscle weakness, becoming relentlessly immobile,
developing impaired speech, and respiration problems. In the
late stages of the disease, progressing paralysis can result in a
“locked-in” state in which only residual muscular movement is
possible.
Despite the average life expectancy of about 3 years after symp-
tom onset (Ilzecka et al., 2003), the progression of the disease is
unpredictable, with 10% of patients with ALS living more than
10 years (Andrews, 2009). So far, research has not demonstrated
that it is possible to stop the progression of the disease. Therefore,
the improvement of patients’ quality of life is often considered
one of the primary goals of clinical management (Simmons, 2005;
Pagnini, 2012).
Many psychological issues have been investigated in ALS,
including psychological well-being, anxiety, and depression
(Pagnini et al., 2012a), pain (Brettschneider et al., 2008), hope-
lessness (Plahuta et al., 2002), spiritual and existential well-
being (Dal Bello-Haas et al., 2000). However, no study to
our knowledge has investigated the topics of hate and resent-
ment. Moreover, despite its clinical importance (Fanos et al.,
2008), the issue of hope has received little empirical inves-
tigation. To date, no study has investigated the relationship
among hate, resentment, and hope and their development
through time.
Hate and resentment, as well as hope, are often reported as
a psychological response toward a chronic and non-treatable ill-
ness. Clinical practice (Radunovic et al., 2007), as well as patients’
perspectives (Melazzini, 2007), often report of anger reactions,
expressed in various ways by the patient. Not surprisingly, a study
by Palmieri et al. (2010) observed high levels of anger in the con-
sidered ALS population. The “relationship” established with the
disease seems to change over time (De Groot et al., 2007), prob-
ably because of the advancement of the disease and/or a grief
elaboration process. Clinical practice suggests that ALS is often
the target of hate by the people who have it; resentment is another
emotion expressed by the patients, as well as by their caregivers,
but there are very few scientific data pertaining to those reactions.
The diagnosis of ALS may threaten hope, especially with the
belief that there is nothing that can be done to change a patient’s
fate. However, many clinicians suggest that “hope” is a very impor-
tant issue for the psychological well-being of patients and their
caregivers (Centers, 2001). In the ALS scientific literature, the con-
cept of “hope” is less investigated than the one of “hopelessness”
(Plahuta et al., 2002). Hopelessness is related to depressive features,
and with low levels of quality of life (Ganzini et al., 1999); more-
over, hopelessness seems to predict the desire for assisted suicide
(Ganzini et al., 2002).
Our rationale in this study was to investigate the prevalence and
degree of hate and resentment in a sample of the ALS population,
and to understand their relationships with time since diagnosis,
hope, marital status, and other demographic characteristics. A
further innovation of this research is the examination of these
three variables in relationship to the willingness to extend one’s
longevity through nutritional self-care. This variable was included,
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because clinical considerations made by Oster (the manuscript’s
first author, who is an 18 years ALS survivor) suggest that some
people with ALS would not be willing to adopt a healthier diet
even if it were to be shown to extend life. We wanted to investigate
the prevalence of this mindset in our study’s subject population,
and to discover whether the variables of hate, resentment, and
hope were related to this attitude.
MATERIALS AND METHODS
An online questionnaire was created with a Google spreadsheet,
as part of a larger study. The overall survey was composed by
65 items, with both opened-ended and closed-ended questions;
in case of closed-ended questions, subjects could choose among
different sentences. The time requested to complete the entire sur-
vey ranged between 10 and 20 min. The survey was created with
Google Documents tool and was accessible by subjects through a
dedicated template. All the items were generated ex novo (there-
fore no cut-off-points could be expected). There were no forced
answers. For the purpose of this study, we only used a selected
sub-sample of items.
People with ALS were invited with messages that were posted
in ALS forums, facebook, and a newsletter, as well as with an
announcement on “The Healers” website. The purpose of the sur-
vey was described before subjects were asked to complete the ques-
tionnaire, stating that results would be analyzed only for research
purposes, and there was no possibility to link the published data
to their true identity.
Together with demographical data, subjects were asked to pro-
vide answers about hate, resentment, and hope, with questions like
“Do you believe that there will be a cure for ALS in your lifetime?”
and “What statement best describes the level of resentment that
you feel about living with ALS?” Multiple answers were possible.
The analyses, both descriptive and inferential, were, carried out
with Excel and SPSS software, are mainly descriptive statistics and
cross-tabs analysis, using the Pearson’s chi-squared test.
RESULTS
A total of 83 subjects with ALS completed the survey. The sam-
ple’s characteristics are reported in Table 1. Missing values were
excluded.
The answers provided to the questions are presented in the
Figures 1–5.
People who answered positively to the question about the hope
to live more than 10 years had a lower frequency of resentment,
χ2 (6,N = 82)= 11.14, p< 0.05, and hateχ2 (6,N = 81)= 13.48,
p< 0.05, toward the illness.
The level of resentment of ALS reported by subjects is highly
related to the level of resentment perceived in the caregiver, χ2
(6, N = 81)= 41.09, p< 0.001, and the level of hate toward ALS,
χ2 (6,N = 81)= 58.21, p< 0.001. The caregiver’s resentment per-
ceived by the patient is also related to the level of hate expressed by
the subject,χ2 (6,N = 80)= 21.19, p< 0.05. It seems that there is
a tendency for a positive correlation among these three variables.
Subjects who have the hope to live 10 or more years would
be more willing to follow a strict diet if it would increase the
life expectancy by 1 year χ2 (6, N = 75)= 21.93, p< 0.01, but
no differences were found about the willingness to take a new
drug with uncomfortable side effects. Both the questions about
“hope” presented no differences with regards to the demographic
variables.
Women report higher level of resentment, with higher frequen-
cies of moderate/strong resentment answers, in comparison with
males χ2 (3,N = 81)= 6.44, p< 0.05. There is a similar tendency,
non-significant (p< 0.1), with women reporting a higher hate
level. Splitting the sample into two groups, using the median of
the time since diagnosis, subjects who have had the disease for less
time present with higher level of resentmentχ2 (3,N = 81)= 8.05,
p< 0.05, and hate χ2 (3, N = 82)= 9.89, p< 0.05.
The subjects who report a higher level of caregiver’s resentment
indicate with greater frequency the answer “yes” to the question
“Do you believe that there is a relation between your dietary habits
and the losses that you have experienced subsequent to ALS?” χ2
(9, N = 78)= 20.32, p< 0.05.
Regarding hope, people who do not believe that there will be a
cure for ALS in their lifetime were more likely to believe that they
will not live for 10 years, compared to those who have the hope that
a cure will be found χ2 (1, N = 78)= 4.67, p< 0.05. People who
answered “yes” to both the hope questions (N = 21), compared to
those who answered “no” (N = 11), had ALS for a longer time (but
without statistical differences), were more likely to be married χ2
(5, N = 32)= 13.38, p< 0.05 and reported a lower level of hate
against ALS χ2 (4, N = 32)= 8.06, p< 0.05.
Considering the resentment level expressed by the subjects, in
comparison with the resentment level that the subjects reported to
be experienced by the caregivers, about half of the subjects (51.2%)
express an equal level of resentment, the 21.3% report higher level
of resentment experienced by the patient, while the 27.5% indi-
cate the contrary. No differences arose about demographics or
hope levels reported (all Chi Squares without significant results).
DISCUSSION
The present study from an online survey completed by men and
women with ALS and analyzed with cross-sectional analyses –
aimed to investigate levels of hate, resentment, and hope, and the
relationships among them. These variables were also examined
in relationship to the willingness to extend longevity through a
commitment to disciplined nutritional self-care. To our knowl-
edge, this is one of the first attempts to investigate, with a survey
methodology, the point of view of people with ALS about the hope
for longevity and a cure, and the level of hate and resentment
toward the illness. Furthermore, we are not aware of any study
examining motivation regarding nutritional self-care, related to
the will to live.
In our sample, most of the subjects (70%) hoped to be able to
live more than 10 years. The hope for a cure was somewhat less
present. A third of the people who reported hope of seeing a cure
in their lifetime, and more than half of the sample who reported
not believing that they will have the chance to see a cure. These
two issues were correlated. Interestingly, people in a marriage were
more likely to have hope of living 10 years or longer and more likely
to have lower levels of hate against ALS.
To hate ALS involves hating having ALS and all of the potentially
frustrating and otherwise emotionally challenging experiences
that occur in the lives of people with ALS, as well as hating the
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Table 1 | Sample characteristics (N =83).
Frequency %
Months since diagnosis [M, (SD)] 44.12 (84.32)
Sex Female 41 50
Male 41 50
Marital status Now married 56 68.3
Widowed 4 4.9
Divorced 11 13.4
Separated 3 3.7
Never married 3 3.7
other 5 6.1
Highest degree Less than high school 1 1.2
High school graduate 18 22.2
Some college credit 15 18.5
Associate degree (e.g., AA, AS) 5 6.2
Bachelor’s degree (e.g., BA, AB, BS) 23 28.4
Master’s degree (e.g., MA, MS, MEng, MEd, MSW, MBA) 12 14.8
Professional degree (e.g., MD, DDS, DVM, LLB, JD) 4 4.9
Doctorate degree (e.g., PhD, EdD) 2 2.5
other 1 1.2
Work activity Employed for wages 13 15.9
Self-employed 4 4.9
Unemployed 12 14.6
Retired 39 47.6
Unable to work 13 15.9
Other 1 1.2
Race Asian 1 1.2
Black or African American 1 1.2
White 76 92.7
Hispanic 4 4.9
Country/province USA 73 89
South America 1 1.2
Europe 5 6.1
Australia 1 1.2
Canada 1 1.2
Mexico 1 1.2
Life environment City 28 34.1
Country/Rural 10 12.2
Suburban 28 34.1
Small town 15 18.3
Other 1 1.2
way one’s own physiology is performing. Perhaps, our finding
regarding marriage and hope suggests that people in marriages
may build a vision of hope together, and that the meaning of
their shared marital commitment could be protective against
what is involved in hating one’s life with ALS. Research into this
area could give clinicians greater understanding of strategies that
could facilitate greater hope as well as less resentment and hate
in people with ALS. It must be pointed out that some people
with ALS may value hating and resenting ALS as the best strat-
egy for them in terms of coping and life satisfaction, and we
have much to learn from them about their experiences in living
with ALS.
The majority of the sample indicated a strong or moderate
resentment level; a similar indication was given subjects’ percep-
tion of caregiver resentment level. About a third of the sample
reported sporadic episodes of hate, while less than a fifth of the
subjects indicated to always hate the disease. The current study
suggests a prevalence of these distressing emotional experiences
that is high enough to warrant investigation of the nature of
these experiences and the meanings that they have for the people
having them.
We postulate that there may be cognitive interpretations of
experiences of living with ALS that may increase the likelihood of
experiencing resentment and hatred. If so, then clinicians could
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FIGURE 1 | Do you have hope that you could live 10 years or longer
regardless of whether an effective pharmaceutical treatment were to
be discovered? (N = 82).
FIGURE 2 | Do you believe that there will be a cure for ALS in your
lifetime? (N =78).
work with ALS patients to learn to interpret events in ways that
are less emotionally and physiologically distressing. This is what
was personally observed by Oster, first author of this paper and
an 18 year survivor of ALS, in his self-case study. Oster has experi-
enced much more positive experiences of living with ALS through
working with a psychoanalyst psychologist for over 12 years, and
experiences less hate and resentment toward ALS. Oster states
that he has learned to see the world differently, based to a large
extent upon learning to interpret and understand living with ALS
differently (unpublished data). There are no or very few stud-
ies about psychological interventions in ALS, as recently pointed
noted (Pagnini et al., 2012b). However, psychological treatments
with people with other chronic illnesses presented a high capac-
ity to improve the well-being and to reduce the anger response,
promoting acceptance (Telford et al., 2006).
Other researchers have evaluated that patient hopefulness is the
result of an active style of coping, although their construct of hope
was more comprehensive than our definition (Fanos et al., 2008).
Furthermore, previous research has demonstrated that lower lev-
els of well-being are associated with reduced longevity (Pagnini
et al., 2012a); therefore, we believe that it would be worthwhile
for additional research on the relationship between the variables
of hate, resentment, and hope in relationship to well-being to
help understand whether these variables factor into longevity
with ALS.
The analyses of the relationships among resentment, hate, and
hope provide interesting results. Subjects who reported hope of
living 10 years or more reported less hate and resentment toward
ALS. Further research is required to understand hope in rela-
tionship to hate and resentment, and to answer the following
questions. Is hope in ALS protective regarding the experience of
hating and resenting ALS? And/or, do tendencies to experience
greater hate and resentment regarding losses, challenges, limita-
tions, and frustrations lessen hope in people with ALS? Aside from
the relationship of lower levels of hating ALS being associated
with being married and having hope of surviving 10 years post-
diagnosis, it is unclear from our findings what causes some people
to always hate ALS and others to never hate it. Research is needed
to understand the meanings and experiences of the people who
always hate ALS and those who report to never hate ALS.
Levels of hate and resentment were correlated; moreover, sub-
jects’ estimation of the level of resentment in the caregiver was
related to their own resentment level, without statistical differ-
ences between them. To our knowledge, this is a new finding, yet
there is the issue that our research relied upon the perception
that the person with ALS has of their caregiver. So, we do not
know the extent to which this finding reflects actual symmetry
between the person with ALS and their caregiver. Researchers have
demonstrated symmetry between people with ALS and caregivers
in regards to distress, but this has not been previously studied in
regards to resentment (Rabkin et al., 2000).
There were differences in gender in the report of resentment
and hate related to the illness. Women indicated higher level of
resentment and a higher level of hate, with the latter emotion only
expressing a tendency toward significance. The novelty of this data
suggests caution in its interpretation, but a possible explanation is
that women are more devastated by being robbed of their caregiv-
ing role as well as by being forced into being a recipient. Cultural
norms may play a role in gender differences found. Cultural norms
emphasize the physical appearance of the woman being linked to
feeling valued, loved, included, but the perception of the body after
the diagnosis of ALS may be related to discard, pity, and contempt.
Furthermore, men may have a tendency to have been recipients of
nurturing and caregiving from not only mothers but also wives,
therefore adapting more easily to being put in the role of being
taken care of. Further investigations and data are required regard-
ing these cautious interpretations, as well as regarding whether or
not some of women’s greater resentment than men about ALS
is related to some extent to greater distress with receiving the
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FIGURE 3 |What statement best describes the level of resentment that you feel about living with ALS? (N =83).
FIGURE 4 |What statement do you guess best describes the level of resentment that your primary caregiver feels about living with ALS in their life?
(N =80).
very personal assistance required with urination and bathing as
a recipient of caregiving.
The time since diagnosis is another issue that discriminates
hate and resentment levels, as well as reported hope. In our sam-
ple, subjects who have had ALS for a longer time reported higher
levels of hope as well as lower levels of both hate and resent-
ment. A possible explanation to these findings may be related to
the relationship established with the illness and a grief elabora-
tion process. Living with the illness could promote its acceptance;
therefore, the amount of time spent with ALS may play a positive
role in diminishing hate and resentment toward the illness. More-
over, the reason why people who survive ALS longer have more
hope of living longer could be related to the course of the illness
being less quick than initially perceived, resulting in less hate and
resentment toward ALS.
In the light of our findings, and because of the quality of life
issues involved, we suggest that clinicians attempt to understand
the meanings of patients’ hate and resentment toward ALS and
not take it at face value. Although, it appears that the passage of
time may in many cases increase hope and decrease both hate and
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FIGURE 5 |What statement most accurately describes your feelings in the last 6months regarding “hating”ALS? (N =82).
resentment, it is possible that some people could get stuck in the
grieving process because of the immensity of the losses that may
occur with ALS.
The investigation of hope provided interesting results about
the motivation toward following medical indications. The subjects
who have the hope to live more than 10 years or more reported, as a
group, more willingness to follow a strict nutrient-dense diet if sci-
entific research indicated that such a diet increased life expectancy
by 1 year, but declared that they would not agree to consume drugs
with uncomfortable side effects, even if these would increase life
expectancy by 1 year. It seems likely that people who already have
the hope to maintain a positive level of quality of life may be
more interested in maintaining it, as compared to worsening their
quality of life to gain 1 year of survival.
It is noteworthy that some subjects, whether or not they have
the hope of 10 years survival, would be willing to sacrifice 1 year of
life rather than eating a nutrient-dense diet if it were demonstrated
to be healthier for ALS. 18% (14 subjects) of the population in our
study would be willing to refrain from a healthier diet, instead
of extending their lives by 1 year. Slightly less than 5% (four sub-
jects) of the population in our study would be willing to refrain
from a healthier diet, instead of extending their lives by two or
more years. To our knowledge, this is the first time that people
with ALS have reported and been documented to be willing to
sacrifice months off of their lives in order to eat whatever they
desire. One subject in our study, whose response was categorized
as “other” stated that they would only follow a life extending diet
if it tasted good. Others reported that it would depend upon the
quality of life that they would have, if they were to practice the
hypothetical diet.
Additional research is required to discover what the meanings
are for the people with ALS who would cut their lives short, rather
than choose to focus on their longevity through life style changes.
It appears that there is a cost-benefit analysis going on in terms
of time, given that over three times as many subjects (14 of them)
would refrain from a nutrient-dense diet that would extend their
lives for a single year, as compared to the subjects (only four
of them) who would refrain from consuming a nutrient-dense
diet that would extend their lives by two or more years. Research
is needed to understand whether or not actual self-care dietary
behavioral choices are predictive of longevity in a way other than
what has been established about people with ALS who maintain
weight having a greater longevity (Paganoni et al., 2011). Another
area deserving research is whether or not hope in ALS is related to
longevity, mediated by self-care dietary behavioral choices, dietary,
or otherwise.
Caregivers’ resentment, as perceived by the subjects, is related
to subjects’ reports of whether their dietary habits have changed
as a result of losses associated with the disease. Perhaps this
reflects a sense of guilt in the person with ALS, in relationship
to the caregiver to whom they may feel burdensome. Some pre-
vious papers have reported on a sense of feeling guilty toward
the caregiver as one of the most distressing issues for a person
with ALS (Bolmsjo, 2001). It seems possible that if a subject indi-
cates higher caregiver resentment, that the reported perception
of caregiver’s resentment could be to some extent a projection
of an inner sense of guilt. Another possibility is that the person
may accurately perceive the high resentment of the caregiver, and
therefore experience some guilt that leads to his/her having a lower
enjoyment of life, including dietary habits. Clinically addressing
and attenuating caregivers’ resentment could possibly reduce the
ALS diagnosed persons’ resentment level, to the extent that part
of the latter’s resentment of ALS is related to being dependent
upon a caregiver with high resentment. Previous research has
demonstrated that caregiver depression is related to the depres-
sion experienced by the patient, and therefore, addressing caregiver
depression may also reduce patient distress (Pagnini et al., 2010,
2012a).
Frontiers in Psychology | Psychology for Clinical Settings November 2012 | Volume 3 | Article 530 | 6
Oster and Pagnini Resentment, hate, and hope in ALS
This study presents some limitations. The use of non-validated
instruments, such as the survey questions that we have created,may
reduce the validity of the results. Further studies with validated
questionnaires about anger, hate, and resentment are warranted.
The cross-sectional design does not allow any causal inferences
between variables, even if these can be discussed in the inter-
pretation. Moreover, the sample size was small and it is possi-
ble that some correlations would be underestimated. Finally, the
choice of an Internet-based survey may limit the external valid-
ity of the study to people with ALS who have access to Internet,
and who can easily communicate with a keyboard, augmentative
communication, or with personal assistance. The self-selection
of the sample may further reduce the generalizability of results,
and there was no premorbid attitudinal assessment to compare
to the current attitudes. The only inclusion criteria was a self-
reported diagnosis of ALS, and we had no chance to verify this
information. However, subjects did not receive any compensa-
tion, therefore we consider the chance of subjects’ participation
without ALS not probable. Moreover, there is a balance between
male and females in our sample, but it seems that ALS is lightly
more prevalent in males, suggesting that the sample could be
non-completely representative. Therefore, further studies with
representative samples, longitudinal and experimental designs are
required to confirm and deepen the findings presented in this
paper.
CONCLUSION
The present study is a first attempt to investigate hate, resentment,
and hope in ALS, in relationship to each other and in relation-
ship to the willingness to follow a strict nutrient-dense diet, if it
were shown to increase longevity. We conducted an online survey,
where people with ALS were directly invited to provide answers.
Results indicate that there is a massive presence of hope in our sam-
ple, with heterogeneous levels of hate and resentment; the three
constructs were interrelated. Subjects with hope of living 10 years
or more were more likely to report a willingness to make dietary
lifestyle changes if such changes were demonstrated to increase
longevity. Resentment and hate tended to be higher in people who
have had ALS for less time, and in women. People who have lived
with ALS for more time expressed a higher level of hope to live
10 years or more.
The main findings of this research indicate that hate, resent-
ment, and hope could be important issues to investigate in future
ALS studies. Their roles in the acceptance process of the illness,
and how hate and resentment feelings as well as hopelessness
may be clinically treated, are important topics to be explored
by ALS researchers and clinicians. In particular, the develop-
ment of specific psychological interventions, or research about
existing psychological treatments applied to people with ALS,
seems important to improve patients’ and caregivers’ quality of
life (Pagnini et al., 2012b).
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